Journal of Clinical Pharmacy and Therapeutics · 2015 · 19 citations · 24 references
MedicinePharmacokineticsPharmacologyDrug MetabolismPharmacogeneticsPharmacogenomicsCytochrome P450 EnzymesCytochrome P450-mediated MetabolismDrug Metabolism GeneticsMetabolic VariabilityMetabolism VariabilityPharmacogenetic TestingAntiplatelet DrugsClopidogrel Pharmacogenetic TestingCyp2c19 Drug MetabolismCyp2c19 GenotypeCyp2c19 PharmacogeneticsCytochrome P450 2C19 GenotypingCytochrome P450 Genetic PolymorphismCytochrome P450 Genotyping
WHAT IS KNOWN AND OBJECTIVE: Variation of the cytochrome P450 2C19 gene coding for the CYP2C19 enzyme has been reported to be associated with clopidogrel response variability. The activity of the CYP2C19 enzyme is genetically influenced by polymorphisms of its gene. METHODS: This study was conducted to assess the impact of CYP2C19 polymorphism on the clopidogrel metabolism, indirectly selecting the plasma concentration ratios of clopidogrel to its inactive metabolite SR26334 as an evaluation index. Genotyping and plasma concentration results of 366 patients on clopidogrel maintenance therapy (75 mg daily dose) were analysed in this study. CYP2C19 genotypes were determined by PCR-restriction fragment length polymorphism method. RESULTS AND DISCUSSION: As for CYP2C19, patients were classified into three metabolism genotype groups: EM (44·3%), IM (43·4%) and PM (12·3%). The mean plasma concentration ratio of clopidogrel to its inactive metabolite SR26334 for the entire sample was 0·507. The plasma concentration ratios of the 3 metabolism groups were significantly different (P < 0·001). The lowest plasma concentration ratio value was observed for PM patients. WHAT IS NEW AND CONCLUSION: Polymorphism of CYP2C19 was significantly associated with plasma concentration ratios of clopidogrel to its inactive metabolite SR26334. Clopidogrel metabolism was regulated by CYP2C19. The *2 and *3 allele carriage were independently associated with the antiplatelet effect of chronic clopidogrel therapy.
24
Cytochrome P-450 Polymorphisms and Response to Clopidogrel
Jessica L. Mega, Sandra Close, Stephen D. Wiviott et al. · New England Journal of Medicine · 2008 · 2.5K citations · Full text
Medicine, Cardiology, Pharmacology +17
Miho Kazui, Yumi Nishiya, Tomoko Ishizuka et al. · Drug Metabolism and Disposition · 2009 · 821 citations
Medicine, Biochemistry, Pharmacology +17